The Evolution of the Meningitis Vaccine Project

Background. In 2001, the Meningitis Vaccine Project (MVP) was tasked to develop, test, license, and introduce a group A meningococcal (MenA) conjugate vaccine for sub-Saharan Africa. African public health officials emphasized that a vaccine price of less than US$0.50 per dose was necessary to ensure...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiffay, Kathleen, Jodar, Luis, Kieny, Marie-Paule, Socquet, Muriel, LaForce, F. Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639496/
https://www.ncbi.nlm.nih.gov/pubmed/26553666
http://dx.doi.org/10.1093/cid/civ594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639496/
https://www.ncbi.nlm.nih.gov/pubmed/26553666
http://dx.doi.org/10.1093/cid/civ594

Ejemplares similares